Where does Handa Oncology, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Handa Oncology, LLC ranks #35,624 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Handa Oncology, LLC hold?

Handa Oncology, LLC holds 7 US utility patents granted between 2021 and 2025, spanning 5 technology areas.

What is Handa Oncology, LLC's Innovation Score?

Handa Oncology, LLC has an Innovation Score of 30.0 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Handa Oncology, LLC focus on?

Handa Oncology, LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 7 patents, ranking #2,588 of 6,058 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Handa Oncology, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Handa Oncology, LLC.

What does claim depth mean for Handa Oncology, LLC's patents?

Handa Oncology, LLC's patents average 19.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Handa Oncology, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Handa Oncology, LLC

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Handa ranks #35,624 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#35,624
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.0/100): 19.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R35624 · US Corporation #35,624 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #35,624/49,997
PHOTO-FINISH Hamilton International
CPC-NARROW A61P · 5 areas
INNOV-THIN 30.0/100
CLAIMS-RICH 19.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Hamilton International AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Handa’s 30.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (24%) Velocity 3.3 pts (11%) Breadth 7.9 pts (26%) Claim depth 11.6 pts (39%)

Qualcomm Incorporated · highest

85
Handa Oncology · this assignee

30
3D Lighting… · lowest

7

What this shows Handa's Innovation Score is 30.0/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Handa?

Each dot is one of Handa’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Handa’s own 19.3 claims/patent is ABOVE the 7.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Handa vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Handa's grants concentrate

Handa Oncology, LLC is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (4 grants) versus a trough of 2 in 2024. By volume, Handa sits between Hamilton International AG and Hans Künz GmbH.

Handa's three-year grant acceleration

Handa Oncology, LLC shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hamilton Internat…

7
Hammel Companies

7
Hammerhead Indust…

7
Hanam Artec

7
Handle Tech (SZ)

7
Hank Technology

7
Hanon Systems Bad…

7
Hans Künz

7
Handa Oncology ◀

7

What this shows Handa holds 7 patents at rank #35,697, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Handa

By rank, the assignees closest to #35,697 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Handa's primary technology class.

Handa's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Handa Oncology, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	4	57.1%
2024	2	28.6%
2025partial year	1	14.3%

Which technologies does Handa Oncology, LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07D - Heterocyclic Compounds 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Handa Oncology, LLC's patent record in context - here's where to go next.

Handa Oncology, LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #35,624 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Handa Oncology, LLC against Hamilton International AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.